Existing Substances Risk Assessment Bureau, Health Canada, Ottawa, ON, Canada.
Health Products Laboratory Longueuil, Regulatory Operations and Enforcement Branch, Health Canada, Longueuil, QC, Canada.
J Trace Elem Med Biol. 2021 Dec;68:126830. doi: 10.1016/j.jtemb.2021.126830. Epub 2021 Jul 31.
As part of Government of Canada's Chemical Management Plan, substances containing aluminum (Al), bismuth (Bi), cerium (Ce), chromium (Cr), germanium (Ge), lanthanum (La), lithium (Li), neodymium (Nd), praseodymium (Pr), tellurium (Te), titanium (Ti) and yttrium (Y) were identified as priorities for risk assessment. Generating exposure estimates from all routes of exposure from multiple sources using a traditional approach for these elements can be challenging. The use of human biomonitoring (HBM) data would allow for direct and more precise assessment of the internal concentrations from all routes and all sources of exposure. There are no Canadian or North American population-level whole blood HBM data for the elements listed above. Therefore, this is the first biomonitoring project carried out to determine the concentrations of these elements from a nationally representative sample of Canadians.
The objective of this study was to generate whole blood concentrations for Al, Bi, Ce, Cr, Ge, La, Li. Nd, Pr, Te, Ti and Y in the Canadian population using biobank samples from the Canadian Health Measures Survey (CHMS) cycle 2 (2009-2011) for use in characterizing exposure in screening assessments and for establishing baseline concentrations to determine how exposures are changing over time.
The sample analysis was conducted by ICP-MS. A rigorous quality control and quality assurance process was implemented in order to generate data with high accuracy and precision while measuring low concentrations and minimizing possible inadvertent contamination.
Of the elements analysed, the whole blood concentrations (μg/L) of Al, Ce, Cr, Ge, La, Nd, Pr, Te, Ti and Y in the Canadian population aged 3-79 years were below their respective method reporting limit (MRL). Two elements, Bi and Li were detected in 5 % and 66 % of the Canadian population. The median Li concentration was 0.47 μg/L.
The results of this study provide information on concentrations of these elements in the Canadian population which can be utilized to characterize exposure in screening assessments and there by the potential for harm to human health. In addition, this study provides baseline HBM data which can be used as a comparative HBM dataset for other populations with similar exposure patterns.
作为加拿大政府化学品管理计划的一部分,含铝(Al)、铋(Bi)、铈(Ce)、铬(Cr)、锗(Ge)、镧(La)、锂(Li)、钕(Nd)、镨(Pr)、碲(Te)、钛(Ti)和钇(Y)的物质已被确定为风险评估的优先事项。使用传统方法从多个来源的所有暴露途径生成这些元素的暴露估计值可能具有挑战性。使用人体生物监测 (HBM) 数据可以直接更准确地评估来自所有途径和所有暴露源的内部浓度。目前尚无上述元素的加拿大或北美人群水平全血 HBM 数据。因此,这是首次开展生物监测项目,以确定来自加拿大具有代表性的全国样本中这些元素的浓度。
本研究的目的是利用加拿大健康测量调查 (CHMS) 周期 2(2009-2011 年)的生物库样本,生成加拿大人群全血中 Al、Bi、Ce、Cr、Ge、La、Li、Nd、Pr、Te、Ti 和 Y 的浓度,用于特征描述筛选评估中的暴露情况,并建立基线浓度以确定暴露随时间的变化情况。
样品分析采用 ICP-MS 进行。为了生成高精度和高精确度的数据,同时测量低浓度并最大程度减少可能的无意污染,实施了严格的质量控制和质量保证流程。
在所分析的元素中,3-79 岁加拿大人群的全血浓度(μg/L)低于各自的方法报告限(MRL)。有两种元素,Bi 和 Li,在 5%和 66%的加拿大人群中被检测到。Li 的中位数浓度为 0.47μg/L。
本研究结果提供了加拿大人群中这些元素浓度的信息,可用于描述筛选评估中的暴露情况,从而评估对人类健康的潜在危害。此外,本研究提供了 HBM 基线数据,可作为具有类似暴露模式的其他人群的比较 HBM 数据集使用。